Sales Team Diligence: What to Inspect in the People, Pipeline and Process

Sales Team Diligence: What to Inspect in the People, Pipeline and Process

You are three weeks from close. The target shows 40% year-over-year revenue growth, healthy gross margins, and a sales team of eight. The model assumes this trajectory continues. But when you pull the CRM data, you find that two reps closed 71% of last year’s bookings. One is the founder’s college roommate who has been there since day one. The other gave notice two months ago and is in a 90-day garden leave. The pipeline the management team presented in the CIM? Half of it has been sitting at “verbal commit” for nine months.

This is the scenario that makes sales due diligence essential. Revenue concentration at the customer level gets flagged in every deal. Revenue concentration at the rep level often does not, until the first post-close quarter misses plan by 35%.

Sales due diligence determines whether a target’s commercial engine is a transferable, scalable asset or a collection of relationships that walk out the door with two people. For deal teams evaluating a platform investment, operating partners planning a value creation thesis, or portfolio executives approaching an add-on, the question is the same: can this sales organization produce predictable, repeatable revenue under new ownership?

This guide walks through the specific areas to examine, the red flags that matter, and a scoring framework you can apply in confirmatory diligence or the first 100 days.

Revenue That Lives in Two Reps’ Heads

Sales team concentration risk is one of the least examined and most consequential issues in lower middle market deals. According to Bain’s 2024 Global Private Equity Report, commercial underperformance remains the leading cause of value destruction in buyouts, and sales execution gaps account for a significant share of missed plans in the first 18 months of ownership.

The problem compounds because sellers and management teams have every incentive to present aggregate metrics. Total bookings, total pipeline, total headcount. The distribution underneath those totals reveals whether you are buying a system or buying a few talented individuals who happen to work there.

Why This Matters at Close

If two reps generate most of the revenue and one leaves within six months of close, your baseline forecast is immediately at risk. Retention packages and earnouts can mitigate this, but only if you identify the dependency during diligence. Otherwise, you are negotiating blind.

Why This Matters in the First 100 Days

If you inherit a sales team where top performers operate on relationships and tribal knowledge rather than documented process, you cannot scale the team, cross-train new hires, or integrate an add-on’s sales function without months of discovery work. The integration thesis depends on sales capacity that may not actually exist.

A thorough commercial due diligence checklist for B2B acquisitions should include rep-level analysis as a standard workstream, not an optional deep dive.

Rep-Level Productivity and Key-Person Dependency

Start with the distribution of closed-won revenue by rep for the trailing 24 months. You want to see:

  • What percentage of total bookings each rep contributed
  • Whether top-performer concentration is increasing or decreasing over time
  • How many reps are at or above quota versus how many are below 50% of target
  • Tenure of top performers and any retention arrangements already in place

A healthy sales team shows a distribution where at least 60% of reps are within 20% of quota, with no single rep contributing more than 25% of total bookings. When you see a Pareto distribution where two people drive 70% of revenue, you are not buying a sales team. You are buying two people and some overhead.

Assessing Key-Person Risk

For any rep contributing more than 20% of trailing twelve-month bookings, document:

  • Current compensation versus market benchmarks
  • Equity or deferred compensation that vests post-close
  • Relationship depth with major accounts (are they the primary contact, or is there institutional relationship coverage?)
  • Non-compete and non-solicit provisions in their employment agreement

McKinsey’s research on talent retention in M&A shows that key employee departures in the first year correlate strongly with deal underperformance. In sales-driven businesses, this correlation is even more pronounced.

Rep-Level Revenue Concentration Analysis | TABLE with columns: Rep Name | TTM Bookings | % of Total | Quota Attainment |

Pipeline Quality and Pipeline Theatre

Every target will present a pipeline. The question is whether it represents genuine future revenue or a collection of stale opportunities that sales leadership keeps alive to hit coverage ratios.

Pull the full pipeline from the CRM and examine:

  • Age distribution: What percentage of pipeline value has been in the current stage for more than 90 days? More than 180 days?
  • Stage progression velocity: What is the median time to move from qualification to proposal? From proposal to close?
  • Win rates by stage: Are the win rates management quoted based on actual historical conversion, or are they aspirational?
  • Pipeline coverage ratio: What is the ratio of weighted pipeline to the next quarter’s target? Is that ratio based on realistic or inflated probabilities?

Red Flags in Pipeline Analysis

Watch for these patterns:

  • Opportunities that have been “closing next month” for six months
  • Large deals with probability ratings that never change despite no activity
  • Coverage ratios that rely heavily on a few mega-deals that have not progressed
  • Win rates that differ significantly when calculated from CRM data versus management estimates

Solid GTM due diligence and revenue quality analysis requires looking at pipeline data with skepticism. The CRM is only as reliable as the discipline used to maintain it.

According to Gartner’s research on sales operations, organizations with high CRM data quality see 15-20% higher forecast accuracy than those with poor data hygiene. If the target’s CRM is a mess, your pipeline analysis is already compromised.

Quota Attainment and Ramp Reality

Quota attainment rates tell you whether the sales targets are realistic and whether the team can hit them. But the aggregate number is less useful than the distribution.

Examine:

  • Attainment distribution: What percentage of reps hit 80%+ of quota? What percentage are below 50%?
  • Quota-setting methodology: Are quotas set top-down from revenue targets, or bottoms-up from territory and account analysis?
  • Quota changes: Were quotas adjusted mid-year? How often? By how much?
  • Ramp time for new hires: How long does it take a new rep to reach full productivity? Is this documented or anecdotal?

Ramp Time Matters for Growth Assumptions

If your investment thesis assumes adding four reps to double sales capacity, you need to know how long those reps take to become productive. If historical ramp time is 9-12 months and your model assumes new hires contribute at full run rate in month three, you have a planning gap.

Ask for data on every rep hired in the last three years: start date, first closed deal, time to full quota, and current status (still employed or departed). This gives you actual ramp evidence rather than management’s estimate.

Sales Ramp Reality Check | 4-step horizontal timeline showing: Hire Date → First Qualified Opportunity (Week 6-8) → Firs

Comp Plan and Incentive Alignment

Compensation structure drives sales behavior. If the comp plan incentivizes behaviors that conflict with the post-acquisition strategy, you will face friction in execution.

Examine:

  • Base vs variable mix: What is the on-target earnings structure? Is it competitive for the market and role?
  • Accelerators and decelerators: Are there meaningful incentives for overperformance? Consequences for underperformance?
  • What gets commissioned: Is commission based on bookings, revenue recognition, or cash collected? Are there clawbacks for churn?
  • Strategic alignment: Does the comp plan reward behaviors that support your value creation thesis (land-and-expand, multi-year contracts, cross-sell)?

Common Comp Plan Issues

  • Plans that pay full commission on first-year value regardless of contract length, incentivizing short-term deals over durable revenue
  • No clawback provisions, meaning reps are paid on deals that churn within 90 days
  • Territory or account assignment that creates conflicts between reps or with channel partners
  • Commission rates that were set when the company was smaller and are now unsustainably high as deal sizes grow

Comp plan restructuring post-close is disruptive and often triggers departures. Understanding the current structure during diligence lets you plan changes thoughtfully rather than reactively.

Process, Tooling and CRM Discipline

A sales team that operates on repeatable process can be scaled and integrated. A sales team that operates on individual heroics cannot.

Assess:

  • Sales process documentation: Is there a defined sales methodology? Are stages clearly defined with exit criteria?
  • CRM usage: Is opportunity data entered consistently? Are activities logged? Can you reconstruct a deal’s history from the CRM?
  • Forecasting discipline: How are forecasts generated? Are they based on weighted pipeline, commit calls, or something else? How accurate have forecasts been historically?
  • Tech stack maturity: What tools are in place? CRM, sales engagement, CPQ, conversation intelligence? Are they actually used or shelfware?

What to Look for in CRM Data

Request a CRM data export and check:

  • Percentage of opportunities with complete required fields
  • Activity logging frequency (calls, emails, meetings) per opportunity
  • Stage progression patterns (are opportunities moving through stages or jumping directly to closed-won/closed-lost?)
  • Forecast accuracy: compare historical forecasts to actual results for the trailing six quarters

If the CRM is poorly maintained, your ability to conduct sales pipeline analysis is limited, and you should discount management’s pipeline and forecast claims accordingly.

For portfolio companies already under ownership, regular portfolio company operating reviews with commercial KPIs should include CRM health metrics as a leading indicator of sales execution risk.

CRM Health Assessment | TABLE with columns: Metric | Target | Actual | Gap — rows: Opportunity Field Completion (>90%),

Sales Diligence Question Set

Use this question set in management presentations and data room requests to surface the issues covered above.

Rep-Level Performance

  • Provide trailing 24-month bookings by rep, by quarter
  • What is the current quota for each rep? What was attainment for each of the last four quarters?
  • Which reps have equity, deferred compensation, or other retention mechanisms?
  • For reps hired in the last three years, provide start date, date of first closed deal, and time to full quota

Pipeline and Forecasting

  • Provide full pipeline export with opportunity create date, stage history, and expected close date
  • What are historical win rates by stage? How were these calculated?
  • Provide forecasts versus actuals for the last six quarters
  • What is the current pipeline coverage ratio? What probability assumptions underlie it?

Compensation and Incentives

  • Provide current comp plans for all quota-carrying roles
  • What triggers commission payment? Are there clawbacks?
  • What changes to comp have been made in the last two years?

Process and Systems

  • Describe the sales process and stage definitions
  • What sales tools are in use? Provide license counts and usage metrics if available
  • Who is responsible for sales operations and forecasting?
  • How are territories and accounts assigned?
Sales Diligence Data Request Sequence | 5-step vertical flow: 1. Rep-Level Bookings (24 months by rep by quarter) → 2. F

Sales Team Diligence Scorecard

Use this scorecard to structure your sales team assessment and create a consistent basis for comparing targets or tracking improvement post-close.

Dimension Metric Green (Low Risk) Yellow (Moderate Risk) Red (High Risk) Score (1-5)
Productivity Spread % of bookings from top 2 reps <40% 40-60% >60%
Key-Person Dependency Any rep >25% of TTM bookings with no retention mechanism None 1 rep 2+ reps
Pipeline Coverage Weighted pipeline / next quarter target (using verified win rates) >3x 2-3x <2x
Pipeline Quality % of pipeline value >180 days in current stage <15% 15-30% >30%
Quota Attainment % of reps at 80%+ of quota (trailing 4 quarters) >70% 50-70% <50%
Ramp Time Months to full productivity for new hires <6 months 6-9 months >9 months
Process Maturity Documented sales process with defined stages and exit criteria Fully documented, followed Documented, inconsistently followed Undocumented or ad hoc
CRM Discipline Opportunity field completion rate >90% 70-90% <70%
Forecast Accuracy Variance between forecast and actual (trailing 6 quarters) ±10% ±10-20% >±20%
Comp Alignment Comp plan incentivizes behaviors aligned with investment thesis Fully aligned Partially aligned, minor changes needed Misaligned, significant restructure required

Scoring guidance: 5 = Green, 3 = Yellow, 1 = Red. Total score out of 50. A score below 30 indicates material sales execution risk that should be reflected in valuation, deal structure, or post-close resourcing.

The Revenue Engine Is the Asset

Sales due diligence is not about validating that a company has salespeople. It is about determining whether the revenue the model assumes can actually be produced by the team, process, and systems you are acquiring.

The issues that sink post-close performance are usually visible in diligence if you look at the right data: rep-level concentration, pipeline age, quota attainment distributions, ramp times, and CRM discipline. These are not exotic metrics. They are the basic operating evidence that separates a durable sales engine from a house of cards.

If your diligence process treats sales team assessment as a qualitative conversation rather than a data-driven workstream, you are taking unnecessary risk. The scorecard and question set in this guide give you a starting point for structured evaluation.

To assess a target’s sales engine with real CRM and attainment data, DevriX can run sales-team diligence as part of commercial due diligence for PE deal teams and operating partners.


Mario Peshev is a 5x CEO and operator, founder of DevriX and Growth Shuttle, global value creation advisor, angel investor, and author of “MBA Disrupted.”

His original background in engineering rode the wave of IT entrepreneurship in the last 25 years, from product and service entrepreneurship through acquiring and selling businesses, to investing in global startups like beehiiv, doola, the Stacked Marketer, Alcatraz, SeedBlink.

Peshev spent over 10,000 hours in consulting and training contracts for mid-market and enterprise organizations like VMware, SAP, Software AG, CERN, Saudi Aramco since 2006. His books and guides are referenced in over 50 universities in North America, Europe, and Asia.


Follow Mario on social:

Latest Editions:

Latest Answers: